New Research Highlights Brain Differences in ADHD, Potential for Targeted Treatments

Attention-deficit/hyperactivity disorder (ADHD) affects an estimated 5.3% of children and adolescents worldwide ¹. Despite being a common neurodevelopmental condition, significant gaps remain in our understanding of its underlying mechanisms, and current medications don’t work equally well for everyone. Recent research led by Nanfang Pan, MD, a radiologist at West China Hospital of Sichuan University, suggests a new approach to understanding ADHD diagnosis and potentially paving the way for more effective, personalized treatments.

Mapping ADHD Heterogeneity Through Brain Networks

Dr. Pan’s work focuses on analyzing brain scans to identify patterns associated with ADHD. His research, along with studies from colleagues like Kun Qin, MD, explores how different brain functional networks operate in individuals with ADHD compared to those without the condition ², ³. A key aspect of this research involves examining the “topology” of these networks – essentially, how different brain regions connect and communicate with each other.

Identifying ADHD Biotypes

Researchers are investigating whether analyzing the structural connections within the brain can reveal distinct subtypes, or “biotypes,” of ADHD ³. By using normative modeling of brain morphometry similarity networks, they aim to identify deviations from typical brain structure that can help categorize individuals with ADHD. This approach could move beyond a one-size-fits-all diagnosis and treatment plan.

Impact of Stimulant Medication on Brain Networks

A study published in February 2026 investigated the effects of mixed amphetamine salts-extended release (MAS-XR) treatment on brain function in youth with ADHD, both with and without a family history of bipolar I disorder ¹. The research found that while MAS-XR normalized brain network abnormalities in those without a family history of bipolar disorder, a decrease in right amygdala efficiency emerged in those with a family history. Changes in network topology were likewise correlated with improvements in ADHD symptoms.

Future Directions and Personalized Treatment

These findings suggest that individuals with a family history of bipolar disorder may respond differently to stimulant medication, highlighting the importance of considering genetic factors in treatment planning. Connectome-based predictive modeling indicates that baseline brain network dysconnectivity can predict treatment outcomes in high-risk individuals. Dr. Pan’s research and similar studies are laying the groundwork for more targeted and effective ADHD treatments based on an individual’s unique brain profile.

Key Takeaways

• ADHD is a heterogeneous condition, meaning it presents differently in different individuals.
• Analyzing brain networks can help identify distinct subtypes of ADHD.
• Stimulant medication affects brain networks differently depending on family history of bipolar disorder.
• Baseline brain network characteristics can predict treatment response.